Showing results (331-340 of 392) with videos related to
Sort By:
Pageof 40
Human Gene Therapy|January 18, 2006
Intravenous and isolated limb perfusion delivery of wild type and a tumor-selective replicating mutant vaccinia virus in nonhuman primatesArpana M Naik, Sricharan Chalikonda, J Andrea McCart, et al.Vaccine|August 6, 2009
Design and evaluation of multi-gene, multi-clade HIV-1 MVA vaccinesPatricia L Earl, Catherine Cotter, Bernard Moss, et al.Proceedings of the National Academy of Sciences of the United States of America|August 22, 2023
Human FAM111A inhibits vaccinia virus replication by degrading viral protein I3 and is antagonized by poxvirus host range factor SPI-1Junda Zhu, Xintao Gao, Yijing Li, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|June 21, 2007
A new multi-clade DNA prime/recombinant MVA boost vaccine induces broad and high levels of HIV-1-specific CD8(+) T-cell and humoral responses in miceAndreas Bråve, Andreas Boberg, Lindvi Gudmundsdotter, et al.Journal of Immunology (Baltimore, Md. : 1950)|November 16, 2010
Preexisting vaccinia virus immunity decreases SIV-specific cellular immunity but does not diminish humoral immunity and efficacy of a DNA/MVA vaccineSunil Kannanganat, Pragati Nigam, Vijayakumar Velu, et al.Virology|May 16, 2002
Comparison of vaccine strategies using recombinant env-gag-pol MVA with or without an oligomeric Env protein boost in the SHIV rhesus macaque modelPatricia L Earl, Linda S Wyatt, David C Montefiori, et al.The Journal of Infectious Diseases|June 2, 2011
Prevention of infection by a granulocyte-macrophage colony-stimulating factor co-expressing DNA/modified vaccinia Ankara simian immunodeficiency virus vaccineLilin Lai, Suefen Kwa, Pamela A Kozlowski, et al.Journal of Virology|June 22, 2007
Characterization of chimpanzee/human monoclonal antibodies to vaccinia virus A33 glycoprotein and its variola virus homolog in vitro and in a vaccinia virus mouse protection modelZhaochun Chen, Patricia Earl, Jeffrey Americo, et al.Virology|May 15, 2007
Recombinant modified vaccinia virus Ankara provides durable protection against disease caused by an immunodeficiency virus as well as long-term immunity to an orthopoxvirus in a non-human primatePatricia L Earl, Jeffrey L Americo, Linda S Wyatt, et al.Proceedings of the National Academy of Sciences of the United States of America|December 26, 2008
A role for the host coatomer and KDEL receptor in early vaccinia biogenesisLeiliang Zhang, Stella Y Lee, Galina V Beznoussenko, et al.Pageof 40